StockData
Gilead Sciences, Inc. logo

Gilead Sciences, Inc. (GILD) operating KPIs

GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.68+5.07 (+3.06%)

Close on Oct 30, 2026Market cap $211.64BP/E –Yield 1.85%

Gilead Sciences total current assets ($M) ($M)

Form 10-Q / 10-K (DB)

Latest, FY2025
18,342
Period ended Dec 31, 2025
Change on a year earlier
-4.3%
19,173 in FY2024
History
18 years
Since FY2008
Sources
17
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTotal current assets ($M) ($M)Year on yearSource
FY2025Dec 31, 202518,342-4.3%Form 10-K (filed 2026-02-24) ↗
FY2024Dec 31, 202419,173+19.2%Form 10-K (filed 2025-02-28) ↗
FY2023Dec 31, 202316,085+11.4%Form 10-K (filed 2024-02-23) ↗
FY2022Dec 31, 202214,443-2.2%Form 10-K (filed 2023-02-22) ↗
FY2021Dec 31, 202114,772-7.7%Form 10-K (filed 2022-02-23) ↗
FY2020Dec 31, 202015,996-47.2%Form 10-K (filed 2021-02-25) ↗
FY2019Dec 31, 201930,296-15.5%Form 10-K (filed 2020-02-25) ↗
FY2018Dec 31, 201835,836+12.6%Form 10-K (filed 2019-02-26) ↗
FY2017Dec 31, 201731,823+62.5%Form 10-K (filed 2018-02-27) ↗
FY2016Dec 31, 201619,588-20.9%Form 10-Q (filed 2017-05-10) ↗
FY2015Dec 31, 201524,762+39.8%Form 10-Q (filed 2016-05-06) ↗
FY2014Dec 31, 201417,714+153.2%Form 10-K (filed 2015-02-25) ↗
FY2013Dec 31, 20136,997+13.7%Form 10-K (filed 2015-02-25) ↗
FY2012Dec 31, 20126,156-55.8%Form 10-K (filed 2013-02-27) ↗
FY2011Dec 31, 201113,919+143.8%Form 10-K (filed 2012-02-23) ↗
FY2010Dec 31, 20105,708+18.6%Form 10-K (filed 2011-02-28) ↗

Cite this data

StockData. (2026). Gilead Sciences Total current assets ($M) ($M), annual FY2008–FY2025 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/fs_tca

See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.